# TEVA Pharmaceuticals USA, Inc. – FDA Inspection, Nov 10, 2022

Source: https://www.keypedia.com/records/fda_inspections/teva-pharmaceuticals-usa-inc/60b2f4fe-ba78-4567-ad4c-c73d6a6ae78d
Source feed: FDA_Inspections

> FDA inspection 1191141 of TEVA Pharmaceuticals USA, Inc., November 10, 2022. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 211. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1191141
- Company Name: TEVA Pharmaceuticals USA, Inc.
- Inspection Date: 2022-11-10
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 3

## Related Documents

- [FDA Inspection 1311564 - 2026-07-20](https://www.keypedia.com/records/fda_inspections/teva-pharmaceuticals-usa-inc/d5e03df0-84ed-480b-bf0b-1df08945fb5a)
- FDA Inspection 1040037 - 2018-01-11
- [FDA Inspection 1000179 - 2017-02-01](https://www.keypedia.com/records/fda_inspections/teva-pharmaceuticals-usa-inc/62583c1b-220e-48ca-9d9e-1c0ccd28fe5c)
- FDA Inspection 854234 - 2013-11-06
- FDA Inspection 775065 - 2012-03-30

Company: https://www.keypedia.com/companies/teva-pharmaceuticals-usa-inc/80ca25b0-727b-44e6-aedf-39bf4f30ef14

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
